Fumarylacetoacetate Hydrolase (Fumarylacetoacetase) (FAH) (C-Term) antibody

Details for Product No. ABIN310198, Supplier: Login to see New
New
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Antigen
Epitope
C-Term
(20), (16), (7), (4), (2), (2), (2), (2), (1), (1), (1)
Reactivity
Dog (Canine), Human, Mouse (Murine), Rat (Rattus), Xenopus laevis, Zebrafish (Danio rerio)
(73), (14), (14), (2), (1), (1), (1), (1)
Host
Rabbit
(62), (11)
Clonality
Polyclonal
Conjugate
Un-conjugated
(6), (4), (2), (2), (2), (2)
Application
Immunohistochemistry (IHC), Western Blotting (WB)
(62), (43), (31), (13), (11), (9), (4), (1), (1)
Pubmed 1 reference available
Supplier Login to see New
Catalog number from supplier Login to see New
Quantity 100 μg
Options
Shipping to United States ( )
Availability
Immunogen Synthetic peptide directed towards the C terminal of human FAH
Sequence AATICKSNFK YMYWTMLQQL THHSVNGCNL RPGDLLASGT ISGPEPENFG
Predicted Reactivity Chicken : 100 %, Dog : 100 %, Horse : 100 %, Human : 100 %, Rat : 100 %, African clawed frog : 90 %, Bovine : 90 %, Rabbit : 90 %, Zebrafish : 90 %
Characteristics This is a rabbit polyclonal antibody against FAH. It was validated on Western Blot and immunohistochemistry.
Purification Protein A purified
Alternative Name FAH (FAH Antibody Abstract)
Background FAH is the last enzyme in the tyrosine catabolism pathway. FAH deficiency is associated with Type 1 hereditary tyrosinemia.This gene encodes the last enzyme in the tyrosine catabolism pathway. FAH deficiency is associated with Type 1 hereditary tyrosinemia (HT).
Molecular Weight 46 kDa
Gene ID 2184
NCBI Accession NP_000128, NM_000137
UniProt P16930
Application Notes Optimal working dilutions should be determined experimentally by the investigator.
Comment

Antigen size: 419 AA

Restrictions For Research Use only
Format Lyophilized
Reconstitution Add 100 µL of distilled water.
Concentration 1 mg/mL
Buffer PBS buffer with 2 % sucrose
Handling Advice Avoid repeated freeze-thaw cycles.
Storage -20 °C
Storage Comment For longer periods of storage, store at -20 °C
Supplier Images
Western Blotting (WB) image for anti-Fumarylacetoacetate Hydrolase (Fumarylacetoacetase) (FAH) (C-Term) antibody (ABIN310198) anti-Fumarylacetoacetate Hydrolase (Fumarylacetoacetase) (FAH) (C-Term) antibody
Immunohistochemistry (IHC) image for anti-Fumarylacetoacetate Hydrolase (Fumarylacetoacetase) (FAH) (C-Term) antibody (ABIN310198) anti-Fumarylacetoacetate Hydrolase (Fumarylacetoacetase) (FAH) (C-Term) antibody (Image 2)
Immunohistochemistry (IHC) image for anti-Fumarylacetoacetate Hydrolase (Fumarylacetoacetase) (FAH) (C-Term) antibody (ABIN310198) Sample Type: Human Liver and Mouse FAH KO liverPrimary Dilution: 1:400
Immunohistochemistry (IHC) image for anti-Fumarylacetoacetate Hydrolase (Fumarylacetoacetase) (FAH) (C-Term) antibody (ABIN310198) Sample Type: Human Liver and Mouse FAH KO liverPrimary Dilution: 1:400
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) image for anti-Fumarylacetoacetate Hydrolase (Fumarylacetoacetase) (FAH) (C-Term) antibody (ABIN310198) Rabbit Anti-FAH Antibody ,Paraffin Embedded Tissue: Human Kidney
Cellular Data...
Immunohistochemistry (IHC) image for anti-Fumarylacetoacetate Hydrolase (Fumarylacetoacetase) (FAH) (C-Term) antibody (ABIN310198) Immunohistochemistry with human liver, mouse KO tissue
Background publications Bliksrud, Brodtkorb, Andresen et al.: "Tyrosinaemia type I--de novo mutation in liver tissue suppressing an inborn splicing defect." in: Journal of molecular medicine (Berlin, Germany), Vol. 83, Issue 5, pp. 406-10, 2005 (PubMed).